全球医疗保健分析测试服务市场 – 2029 年行业趋势和预测

 医疗保健分析测试服务市场分析和规模

医疗保健分析测试服务称为材料测试。医疗保健分析服务用于确认产品质量和纯度。检查制造过程中或产品开发早期阶段可能感染产品的杂质。生物分析测试设备用于确定生物基质中的代谢物和药物。这些服务广泛应用于药物开发、制药、生物技术和医疗器械制造，这将进一步推动医疗保健分析测试服务的市场增长。

Data Bridge Market Research 分析，医疗分析测试服务市场在 2021 年为 121 亿美元，预计到 2029 年将达到 224.5 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 8.03%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

医疗保健分析测试服务市场范围和细分  

Market Definition

Biopharmaceutical, pharmaceutical, and medical device manufacturers widely use healthcare analytical testing services to assist them throughout drug development. This service assists in drug development, from discovery to clinical development or clinical trials to commercialization.

Global Healthcare Analytical Testing Services Market Dynamics

Drivers

• Increased number of laboratory outsourcing service

Outsourcing bioanalytical services are becoming increasingly popular to maximize resource utilization. While dedicated in-house laboratories are equipped with cutting-edge technology, they may be unable to handle complex bioanalytical testing. Furthermore, running in-house laboratories can be costly from a strategic standpoint. Outsourcing the lab role lowers overhead and operational costs, allowing businesses to continue to reap the benefits of such lab services. Lab outsourcing assists businesses and other institutions make money by allowing them to trade higher fixed costs for lower variable costs, reducing the need for capital investment in the company, and providing quick access to world-class analytical expertise and capabilities. The above-mentioned factors are significantly driving market growth.

• Rise in the R&D expenditure in the pharmaceutical and biopharmaceutical industry

In 2012, the pharmaceutical industry spent a total of 136 billion dollars. It spent 186 billion dollars on research and development in 2019. According to PhRMA, member companies' R&D investment totaled 83 billion U.S. dollars in 2019, making the biopharmaceutical industry the most R&D-intensive industry in the U.S. economy. The biopharmaceutical industry invests six times more in R&D than all other manufacturing sectors combined. PhRMA member companies have invested nearly USD 1 trillion in discovering and developing new and improved drugs and cures over the last few decades. Usually, during the pre-clinical phase, the regulatory authority oversees, controls, and eventually authorizes the drugs. Major pharmaceutical research and development advances have begun to alter the R&D landscape in recent years.

• Rising demand for bioanalytical testing services

Rising demand for bioanalytical testing services is one of the major factors driving market growth due to its benefits, such as utility in controlling drug development costs and effectively evaluating the therapeutic entity, resulting in a cost-effective drug development cycle. The healthcare analytical testing services market is expected to grow significantly during the forecast period, owing to the increasing utility of these services in ensuring the quality of pharmaceuticals and biopharmaceuticals before release for sale, supply, or export. These are the factors which helps to grow the market.

Opportunities

• Rise in biosimilar

Analytical testing establishes the physicochemical characterization to prove the "sameness" of the biosimilar to the reference molecule throughout the biosimilar development process. As a result, demand for healthcare analytical testing services is expected to increase in the coming years. For instance, in July 2021, Pfizer was working on 96 biosimilars in a different phase. The company is an industry leader in biosimilars and based in the United States, contributing to the region's growth.

Restraints/Challenges

• High cost of healthcare analytical testing services

High cost of healthcare analytical testing services and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Assays due to high maintenance and instrument costs, stringent regulations on reagent usage and lack of skilled professionals are some key factors expected to hamper growth of the healthcare analytical testing services.

This healthcare analytical testing services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the healthcare analytical testing services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Healthcare Analytical Testing Services Market

The COVID-19 pandemic had a major impact on the global economy and business operations. The COVID-19 pandemic has presented new challenges to the bioanalytical community. The pandemic's impact on business practices, supply chains, timelines, and project prioritization is still being felt across the industry one year later. Because of travel and personnel constraints, laboratories have modified their day-to-day lab operations and clinical trial procedures. Because supply chains have been disrupted, the availability of lab consumables, reagents, personal protective equipment (PPE), and biological matrices has decreased. COVID-19 clinical trials have a broader range of analytical requirements than traditional therapeutic candidates, as each therapeutic may necessitate pharmacokinetic, immunogenicity, biomarker, SARS-CoV-2 antigen, and serological testing.

Recent developments

• In April 2021, SGS SA completed the acquisition of SYNLAB Analytics, a pharmaceutical, food, and environmental testing service provider. As a result of this acquisition, SGS gained over 37 laboratories, with the primary goal of expanding its analytical testing capabilities in pharmaceutical, environmental, and food testing.

• In April 2021, Charles River Laboratories announced the acquisition of Retrogenix Ltd., which provides cell microarray services, air sampling, and quality, to expand its early-stage contract research organization offerings.

Global Healthcare Analytical Testing Services Market Scope

The healthcare analytical testing services market is segmented on the basis of type, usage, end-user and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Bioanalytical testing services
• Cell-based assays
• Virology testing
• Immunogenicity and neutralizing antibody testing
• Biomarker testing
• Pharmacokinetic testing
• Other
• Physical characterization services
• Laser particle size analysis
• Thermal analysis
• Image analysis
• Surface area analysis
• Other
• Method development and validation services
• Extractable and leachable method development and validation
• Process impurity method development and validation
• Stability-indicating method validation
• Cleaning validation
• Analytical standard characterization
• Technical consulting
• Other
• Batch-release testing services
• Dissolution testing
• Elemental impurity testing
• Disintegration testing, hardness testing
• Friability testing
• Other
• Raw Material Testing Services
• Stability testing
• Drug substance stability testing
• Formulation evaluation stability testing
• Accelerated stability testing
• Photostability testing
• Comparative stability testing
• Other
• Microbial testing services
• Microbial limit testing
• Sterility testing
• Endotoxin testing
• Preservative efficacy testing
• Water testing
• Other
• Environmental monitoring services
• Air testing
• Wastewater/ETP testing
• Other

End User

• 制药和生物制药公司
• 医疗器械公司
• 合同研究组织

医疗保健分析测试服务市场区域分析/见解

对医疗保健分析测试服务市场进行了分析，并按上述国家、类型、用途、最终用户和应用提供了市场规模洞察和趋势。

医疗分析测试服务市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于技术进步和对医疗检测服务的需求增加，北美在医疗分析检测服务市场占据主导地位。此外，由于医疗保健行业快速增长和监管改革有利，生物制药公司正将投资重点放在美国市场。

预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率，因为发达经济体的公司增加了对改善区域分析服务的投资，监管机构修改了评估标准以与全球标准保持一致，以及建立了新的设施和联盟以扩大其产品覆盖该地区的各个地方。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

医疗保健分析测试服务市场还为您提供每个国家/地区医疗保健资本设备支出增长、医疗保健分析测试服务市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对医疗保健分析测试服务市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和医疗保健分析测试服务市场份额分析

医疗保健分析测试服务市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对医疗保健分析测试服务市场的关注有关。

医疗保健分析测试服务市场的一些主要参与者包括：

• Almac 集团 (美国)
• Element Materials Technology（英国）
• Eurofins Scientific（卢森堡）
• PPD Inc.（美国）
• 来源 BioScience（英国）
• Intertek Group plc（英国）
• 美国实验室控股公司（美国）
• Charles River Laboratories（美国）
• Medpace（美国）
• 药明康德 (中国)
• IQVIA（美国）
• SGS Société Générale de Surveillance SA（瑞士）
• Intertek Group plc（英国）
• Syneos Health。（英国）
• ICON plc（爱尔兰）
• PPD Inc.（美国）
• Parexel International Corporation。（美国）
• Altasciences。（加拿大）
• BioAgilytix 实验室。（美国）
• LGC 有限公司 (英国)

SKU-56129